164 related articles for article (PubMed ID: 10886138)
1. Hexafluoro-1,25-dihydroxyvitamin D3 has markedly increased potency in inhibiting proliferation of cultured human keratinocytes compared with 1,25-dihydroxyvitamin D3.
Chen TC; Holick MF
Br J Dermatol; 2000 Jul; 143(1):72-8. PubMed ID: 10886138
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.
Chen TC; Holick MF; Lokeshwar BL; Burnstein KL; Schwartz GG
Recent Results Cancer Res; 2003; 164():273-88. PubMed ID: 12899529
[TBL] [Abstract][Full Text] [Related]
3. Similarly potent action of 1,25-dihydroxyvitamin D3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation.
Takahashi H; Ibe M; Kinouchi M; Ishida-Yamamoto A; Hashimoto Y; Iizuka H
J Dermatol Sci; 2003 Feb; 31(1):21-8. PubMed ID: 12615360
[TBL] [Abstract][Full Text] [Related]
4. Increased biological potency of hexafluorinated analogs of 1,25-dihydroxyvitamin D3 on bovine parathyroid cells.
Imanishi Y; Inaba M; Seki H; Koyama H; Nishizawa Y; Morii H; Otani S
J Steroid Biochem Mol Biol; 1999; 70(4-6):243-8. PubMed ID: 10622414
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 26,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 1 alpha,25-dihydroxyvitamin D3 on the resorption of bone explants ex vivo.
Miyahara T; Harada M; Kozakai A; Matsumoto M; Hashimoto K; Inoue H; Yoda K; Nakatsu T; Kajita S; Yamazaki R; Higuchi S; Kozuka H; Nemoto N
J Nutr Sci Vitaminol (Tokyo); 1999 Jun; 45(3):239-49. PubMed ID: 10524344
[TBL] [Abstract][Full Text] [Related]
6. Effects on cultured neonatal mouse calvaria of 1 alpha,25-dihydroxyvitamin D3, 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,26,26,27,27,27-hexafluoro-1 alpha,23S,25-trihydroxyvitamin D3.
Harada M; Miyahara T; Miyata M; Tomita I; Okayachi H; Ikemoto Y; Higuchi S; Otomo S; Kozuka H; Ikekawa N
Bone Miner; 1992 Jul; 18(1):41-9. PubMed ID: 1422297
[TBL] [Abstract][Full Text] [Related]
7. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
Miyahara T; Simoura T; Osahune N; Uchida Y; Sakuma T; Nemoto N; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Chiba H; Iba K; Sawada N
Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462
[TBL] [Abstract][Full Text] [Related]
8. Proliferation and differentiation of cultured human keratinocytes is modulated by 1,25(OH)2D3 and synthetic vitamin D3 analogues in a cell density-, calcium- and serum-dependent manner.
Svendsen ML; Daneels G; Geysen J; Binderup L; Kragballe K
Pharmacol Toxicol; 1997 Jan; 80(1):49-56. PubMed ID: 9148283
[TBL] [Abstract][Full Text] [Related]
9. Effect of a highly potent fluoro analog of 1,25-dihydroxyvitamin D3 on human bone-derived cells.
Kiriyama T; Okamoto S; Ejima E; Kurihara N; Hakeda Y; Ito N; Izumi M; Kumegawa M; Nagataki S
Endocrinology; 1991 Jan; 128(1):81-6. PubMed ID: 1846118
[TBL] [Abstract][Full Text] [Related]
10. Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time.
Okuno S; Inaba M; Nishizawa Y; Morii H
Miner Electrolyte Metab; 1995; 21(1-3):211-6. PubMed ID: 7565452
[TBL] [Abstract][Full Text] [Related]
11. Effect of 1,24R-dihydroxyvitamin D3 on the growth of human keratinocytes.
Matsumoto K; Hashimoto K; Kiyoki M; Yamamoto M; Yoshikawa K
J Dermatol; 1990 Feb; 17(2):97-103. PubMed ID: 2158504
[TBL] [Abstract][Full Text] [Related]
12. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines.
Gniadecki R
Br J Pharmacol; 1997 Mar; 120(6):1119-27. PubMed ID: 9134225
[TBL] [Abstract][Full Text] [Related]
13. Rationale for use and clinical responsiveness of hexafluoro-1,25-dihydroxyvitamin D3 for the treatment of plaque psoriasis: a pilot study.
Durakovic C; Malabanan A; Holick MF
Br J Dermatol; 2001 Mar; 144(3):500-6. PubMed ID: 11260006
[TBL] [Abstract][Full Text] [Related]
14. Effect of hexafluoro-1,25-dihydroxyvitamin D3 and sodium butyrate combination on differentiation and proliferation of HL-60 leukemia cells.
Yoshida M; Tanaka Y; Eguchi T; Ikekawa N; Saijo N
Anticancer Res; 1992; 12(6B):1947-52. PubMed ID: 1363510
[TBL] [Abstract][Full Text] [Related]
15. DNA binding property of vitamin D3 receptors associated with 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3.
Inaba M; Okuno S; Inoue A; Nishizawa Y; Morii H; DeLuca HF
Arch Biochem Biophys; 1989 Jan; 268(1):35-9. PubMed ID: 2463789
[TBL] [Abstract][Full Text] [Related]
16. 1 alpha,24R-dihydroxyvitamin D3 has an ability comparable to that of 1 alpha,25-dihydroxyvitamin D3 to induce keratinocyte differentiation.
Kobayashi T; Okumura H; Azuma Y; Kiyoki M; Matsumoto K; Hashimoto K; Yoshikawa K
J Dermatol; 1990 Nov; 17(11):707-9. PubMed ID: 2094749
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of 26,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,27-hexafluoro-1 alpha,23(S)25-trihydroxyvitamin D3 in ROS17/2.8 cells transfected with a plasmid expressing CYP24.
Miyahara T; Gomyo S; Ueda Y; Ohyama Y; Sigeno C; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Yamamoto M; Sakuma T; Nemoto N
Xenobiotica; 2000 Nov; 30(11):1055-62. PubMed ID: 11197067
[TBL] [Abstract][Full Text] [Related]
18. The antiproliferative and differentiative activities of 1,25-dihydroxyvitamin D3 are potentiated by epidermal growth factor and attenuated by insulin in cultured human keratinocytes.
Chen TC; Persons K; Liu WW; Chen ML; Holick MF
J Invest Dermatol; 1995 Jan; 104(1):113-7. PubMed ID: 7798628
[TBL] [Abstract][Full Text] [Related]
19. Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal and psoriatic keratinocytes.
Hashimoto K; Matsumoto K; Higashiyama M; Nishida Y; Yoshikawa K
Br J Dermatol; 1990 Jul; 123(1):93-8. PubMed ID: 2390499
[TBL] [Abstract][Full Text] [Related]
20. Modification of 1 alpha,25-dihydroxyvitamin D3 metabolism by introduction of 26,26,26,27,27,27-hexafluoro atoms in human promyelocytic leukaemia (HL-60) cells: isolation and identification of a novel bioactive metabolite, 26,26,26,27,27,27-hexafluoro-1 alpha,23(S),25-trihydroxyvitamin D3.
Honda A; Nakashima N; Shida Y; Mori Y; Nagata A; Ishizuka S
Biochem J; 1993 Oct; 295 ( Pt 2)(Pt 2):509-16. PubMed ID: 8240250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
